Skip to main content

DNTH research · 13F holders by reporting quarter

Dianthus Therapeutics, Inc. (DNTH): 13F holders, 2026Q1

The largest share positions in DNTH that the managers Kresmion follows reported on Form 13F for 2026Q1, as filed. The current quarter, the company's SEC filings and its recent events are on the DNTH research page.

DNTH positions held by the managers we follow (2026Q1)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported valueQoQ
CITADEL ADVISORS LLC FundCUSIP 252828108 · 2026Q1$135.2M0.10%n/a
Point72 Asset Management, L.P. FundCUSIP 252828108 · 2026Q1$54M0.09%-44.8%
MILLENNIUM MANAGEMENT LLC FundCUSIP 252828108 · 2026Q1$22M0.02%-60.7%
D. E. Shaw & Co., Inc. FundCUSIP 252828108 · 2026Q1$12.6M0.01%-3.3%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.